0HF3 Stock Overview
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Cencora, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$251.06 |
| 52 Week High | US$254.02 |
| 52 Week Low | US$196.27 |
| Beta | 0.44 |
| 11 Month Change | 8.06% |
| 3 Month Change | 5.60% |
| 1 Year Change | 24.71% |
| 33 Year Change | 115.63% |
| 5 Year Change | 186.30% |
| Change since IPO | 138.02% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0HF3 | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | 3.0% | -0.3% | 2.2% |
| 1Y | 24.7% | -22.7% | 9.0% |
Return vs Industry: 0HF3 exceeded the UK Healthcare industry which returned -22.7% over the past year.
Return vs Market: 0HF3 exceeded the UK Market which returned 9% over the past year.
Price Volatility
| 0HF3 volatility | |
|---|---|
| 0HF3 Average Weekly Movement | 3.0% |
| Healthcare Industry Average Movement | 4.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0HF3 has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: 0HF3's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1871 | 44,000 | Bob Mauch | www.cencora.com |
Cencora, Inc. sources and distributes pharmaceutical products. The company’s U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.
Cencora, Inc. Fundamentals Summary
| 0HF3 fundamental statistics | |
|---|---|
| Market cap | US$48.26b |
| Earnings (TTM) | US$1.51b |
| Revenue (TTM) | US$293.96b |
32.0x
P/E Ratio0.2x
P/S RatioIs 0HF3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0HF3 income statement (TTM) | |
|---|---|
| Revenue | US$293.96b |
| Cost of Revenue | US$284.17b |
| Gross Profit | US$9.79b |
| Other Expenses | US$8.28b |
| Earnings | US$1.51b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.81 |
| Gross Margin | 3.33% |
| Net Profit Margin | 0.51% |
| Debt/Equity Ratio | 557.8% |
How did 0HF3 perform over the long term?
See historical performance and comparisonDividends
0.9%
Current Dividend Yield27%
Payout RatioDoes 0HF3 pay a reliable dividends?
See 0HF3 dividend history and benchmarks| Cencora dividend dates | |
|---|---|
| Ex Dividend Date | Nov 15 2024 |
| Dividend Pay Date | Nov 29 2024 |
| Days until Ex dividend | 14 days |
| Days until Dividend pay date | 0 days |
Does 0HF3 pay a reliable dividends?
See 0HF3 dividend history and benchmarks